financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Biogen's Motor Neurone Disease Treatment Gets UK Regulator Approval
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biogen's Motor Neurone Disease Treatment Gets UK Regulator Approval
Jul 28, 2025 2:58 AM

05:33 AM EDT, 07/28/2025 (MT Newswires) -- Biogen's (BIIB) tofersen, or Qalsody, has received approval from the UK's Medicines and Healthcare Products Regulatory Agency to treat adults with amyotrophic lateral sclerosis associated with a mutation in the superoxide dismutase 1 gene, the agency said Monday.

Amyotrophic lateral sclerosis is a progressive condition that impacts nerve cells in the brain and spinal cord.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Crescent Point Energy Officially Changes Its Name To Veren, Will Trade Under New Symbol From Next Week
Crescent Point Energy Officially Changes Its Name To Veren, Will Trade Under New Symbol From Next Week
May 10, 2024
04:19 PM EDT, 05/10/2024 (MT Newswires) -- Crescent Point Energy Corp. ( CPG ) said Friday that shareholders have voted in favour of changing the company's name to Veren Inc., effective immediately. A statement noted Veren's shares are expected to begin trading under its new symbol VRN on both the TSX and NYSE on or around May 15, 2024. ...
 Kb Home Insider Sold Shares Worth $275,859, According to a Recent SEC Filing
Kb Home Insider Sold Shares Worth $275,859, According to a Recent SEC Filing
May 10, 2024
04:22 PM EDT, 05/10/2024 (MT Newswires) -- Thomas W. Gilligan, Director, on May 09, 2024, sold 3,914 shares in Kb Home ( KBH ) for $275,859. Following the Form 4 filing with the SEC, Gilligan has control over a total of 48,217 shares of the company, with 48,217 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/795266/000079526624000086/xslF345X03/wk-form4_1715372264.xml Price: 71.00, Change: +0.85, Percent Change:...
 Loews Insider Sold Shares Worth $7,740,000, According to a Recent SEC Filing
Loews Insider Sold Shares Worth $7,740,000, According to a Recent SEC Filing
May 10, 2024
04:22 PM EDT, 05/10/2024 (MT Newswires) -- Jonathan M Tisch, Director, Co-Chairman of the Board and a member of the Office of the President, on May 08, 2024, sold 100,000 shares in Loews ( L ) for $7,740,000. Following the Form 4 filing with the SEC, Tisch has control over a total of 7,883,932 shares of the company, with 557,799...
 Freshpet Insider Sold Shares Worth $1,053,376, According to a Recent SEC Filing
Freshpet Insider Sold Shares Worth $1,053,376, According to a Recent SEC Filing
May 10, 2024
04:23 PM EDT, 05/10/2024 (MT Newswires) -- Stephen Macchiaverna, Executive Vice President, Treasurer, on May 08, 2024, sold 8,760 shares in Freshpet ( FRPT ) for $1,053,376. Following the Form 4 filing with the SEC, Macchiaverna has control over a total of 86,039 shares of the company, with 86,039 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1611647/000092963824001756/xslF345X03/form4.xml Price: 120.80, Change: +0.71, Percent...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved